Heward J M, Allahabadia A, Daykin J, Carr-Smith J, Daly A, Armitage M, Dodson P M, Sheppard M C, Barnett A H, Franklyn J A, Gough S C
Department of Medicine, University of Birmingham, Queen Elizabeth Hospital, United Kingdom.
J Clin Endocrinol Metab. 1998 Oct;83(10):3394-7. doi: 10.1210/jcem.83.10.5137.
Early case control studies found association of the DRB1 allele, DR3, with Graves' disease (GD). Recent reports, claim the DQA1 allele, DQA10501, to be the primary susceptibility determinant within the human leukocyte antigen (HLA) class II region. We typed 228 GD patients, 364 controls, and 98 families (parents, GD, and unaffected sibling) at the DRB1, DQB1, and DQA1 loci. The case control study showed an increased frequency in GD, compared to controls, of DRB10304 (47% vs. 24%; pc < 1.4 x 10(-5)), DQB102 (58% vs. 46%; pc < 0.035), DQB10301/4 (42% vs. 28%; pc < 3.5 x 10(-3)) and DQA10501 (67%, vs. 39%; pc < 7 x 10(-6)). The DRB10304-DQB102-DQA10501 haplotype was increased in GD (47%) vs. controls (24%; pc < 1.8 x 10(-5); odds ratio = 2.72). No independent association of these alleles was observed. Preferential transmission of DRB10304-DQB102-DQA10501 from parents heterozygous for the haplotype to GD siblings (72%) was seen in the families (chi2 = 11.95; 1 d.f.; P = 0.0005). Lack of preferential transmission to unaffected siblings (53%; chi2 = 0.19; 1 d.f.; P = NS) excluded segregation distortion. These results show that linkage disequilibrium between GD and the HLA class II region is due to the extended haplotype DRB10304-DQB102-DQA10501.
早期的病例对照研究发现DRB1等位基因DR3与格雷夫斯病(GD)有关联。最近的报告称,DQA1等位基因DQA10501是人类白细胞抗原(HLA)II类区域内的主要易感性决定因素。我们对228例GD患者、364名对照以及98个家庭(父母、GD患者和未患病的兄弟姐妹)的DRB1、DQB1和DQA1基因座进行了分型。病例对照研究显示,与对照组相比,GD患者中DRB10304(47%对24%;pc<1.4×10⁻⁵)、DQB102(58%对46%;pc<0.035)、DQB10301/4(42%对